Samuel Ward Casscells

Dr. Casscells joined Claritas Capital in January 2002, and brings to Claritas Capital over twenty-five years of experience in the practice, management, and business of healthcare with expertise in cardiology, medical devices, and information services.
Dr. Casscells is involved in patient care, teaching and research on vulnerable atherosclerotic plaque.
He currently serves as the John Edward Tyson Distinguished Professor of Medicine and Vice President of Biotechnology for the University of Texas Health Science Center in Houston, TX and is an Associate Director for Cardiology Research at the Texas Heart Institute/St. Luke's Episcopal Hospital.
He has served as the Levy Professor and Chief of Cardiology at University of Texas-Houston Medical School and Memorial Hermann Hospital and has worked in the Cardiology Branch at the National Institutes of Health in Washington, DC, and at the Scripps Institute of Medicine and Science in La Jolla, California working under Nobel Laureate Roger Guillemin, M.D., Ph.D.
Dr. Casscells graduated with a B.S.
in biology from Yale University in 1974 and from Harvard Medical School magna cum laude in 1979, where he won the Reznick Prize for his research with Nobel Laureate Bernard Lown, M.D.
His internship in medicine was at the Beth Israel Hospital in Boston, and during that time his outpatient training was at Harvard Community Health Plan.
He passed the board examination in internal medicine in 1982.
He then completed a cardiology fellowship at Massachusetts General Hospital, which included clinical epidemiology training at the Harvard School of Public Health.
He passed the board examination in cardiovascular disease in 1985.